Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 28-36

  Maxwell, I H ^a,b   Spitzer, A L ^a   Long, C J ^a   Maxwell, F ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

parvovirus vector; tetracycline; transcriptional regulation

Indexed keywords

LUCIFERASE; TETRACYCLINE; VIRUS VECTOR;

ARTICLE; GENETIC TRANSDUCTION; MOLECULAR CLONING; NONHUMAN; PARVOVIRUS; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

CELL LINE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HELA CELLS; HUMANS; LUCIFERASES; PARVOVIRUS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029962802     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Maxwell IH, Maxwell F, Glode LM. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: a possible strategy for inducing cancer cell suicide. Cancer Res 1986; 46: 4660-4664.
2. Maxwell IH, Glode LM, Maxwell F. Expression of diphtheria toxin A-chain in mature B-cells: a potential approach to therapy of B-lymphoid malignancy Leuk Lymphoma 1992; 7: 457-462.
3. Palmiter RD et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987; 50: 435-443.
4. Breitman ML et al. Genetic ablation: programmed lineage suicide by tissue-specific expression of the diphtheria toxin A gene in transgenic mice. Science 1987; 238: 1563-1565.
5. Harrison GS et al. Inhibition of HIV-1 production resulting from transducrion with a retrovirus containing an HIV-regulated diphtheria toxin A-chain gene. Hum Gene Ther 1992; 3: 461-469
6. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993; 3: 499-503.
7. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
8. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992; 158: 97-129.
9. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 1987; 33: 91-173.
10. Majaniemi I, Siegl G. Early events in the replication of parvovirus LuIII. Arch Virol 1984; 81: 285-302.
11. Maxwell IH et al. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum Gene Ther 1993; 4: 441-450.
12. Berns KI, Labow MA. Parvovirus gene regulation. J Gen Virol 1987; 68: 601-614.
13. Russell SJ et al. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 1992; 66: 2821-2828.
14. Dupont F et al. Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J Virol 1994; 68: 1397-1406.
15. Maxwell IH et al. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice. J Gen Virol 1993; 74: 1175-1179.
16. Diffoot N, Chen KC Bates RC, Lederman M. The complete nucleotide sequence of parvovirus LuIII and localization of a unique sequence possibly responsible for its encapsidation pattern. Virology 1993; 192: 339-345.
17. Maxwell IH, Brown JL, Maxwell F. Inefficiency of expression of luciferase reporter from transfected murine leukemia proviral DNA may be partially overcome by providing a strong polyadenylation signal. J Gen Virol 1991; 72: 1721-1724.
18. Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991; 103: 171-177.
19. Ptashne M. How eukaryotic transcriptional activators work. Nature 1988; 335: 683-689.
20. Maxwell IH, Harrison GS, Wood WM, Maxwell F. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription in transfected mammalian cells. BioTechniques 1989; 7: 276-280.
21. Ma J, Ptashne M. Deletion analysis of GAL4 defines two transcriptional activating segments. Cell 1987; 48: 847-853.
22. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
23. Maxwell IH, Maxwell F. A modified plaque assay and infected cell hybridization assay for wild-type and recombinant LuIII autonomous parvovirus. BioTechniques 1994; 16: 877-881.
24. Flotte TR et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 1993; 268: 3781-3790.
25. Gossen M, Bujard H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res 1993; 21: 4411-4412.
26. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
27. Maniatis T, Fritsch EF, Sambrook J (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1982.
28. Boissy R, Astell CR. An Escherichia coli recBCsbcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5′-terminal palindrome of minute virus of mice. Gene 1985; 35: 179-185.
29. De Wet JR et al. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7: 725-737.
30. Maxwell IH, Maxwell F. Electroporation of mammalian cells with a firefly luciferase expression plasmid: kinetics of transient expression differ markedly among cell types. DNA 1988; 7: 557-562.
31. Diffoot N et al. Identical ends are not required for the equal encapsidation of plus- and minus-strand parvovirus LuIII DNA. J Virol 1989; 63: 3180-3184.
32. Nordeen SK. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 1988; 6: 454-457.